The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis

NCT ID: NCT03775590

Last Updated: 2021-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-21

Study Completion Date

2019-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the efficacy of water bath, water + bleach, and water + vinegar (acetic acid) in the treatment of atopic dermatitis (eczema)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To perform a randomized controlled study to evaluate the efficacy of adding dilute acetic acid to the bath twice weekly on the Eczema Area and Severity Index (EASI) score as compared to adding dilute bleach to the bath including a control arm in which no solution is added to the bath.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis Eczema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

There are 3 study arms with 50 subjects in each arm. The 3 arms are: water, water + bleach, and water + vinegar
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Water

Subjects will bathe at least twice a week in a water bath for 6 months and keep a record of their bathing regimen

Group Type ACTIVE_COMPARATOR

Water

Intervention Type PROCEDURE

To evaluate using water in the treatment of atopic dermatitis

Bleach

Subjects will bathe at least twice a week in a water + dilute bleach bath for 6 months and keep a record of their bathing regimen

Group Type ACTIVE_COMPARATOR

Bleach

Intervention Type PROCEDURE

To evaluate using water + dilute bleach in the treatment of atopic dermatitis

Acetic acid

Subjects will bathe at least twice a week in a water bath + vinegar for 6 months and keep a record of their bathing regimen

Group Type ACTIVE_COMPARATOR

Acetic acid

Intervention Type PROCEDURE

To evaluate using water + vinegar in the treatment of atopic dermatitis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Water

To evaluate using water in the treatment of atopic dermatitis

Intervention Type PROCEDURE

Bleach

To evaluate using water + dilute bleach in the treatment of atopic dermatitis

Intervention Type PROCEDURE

Acetic acid

To evaluate using water + vinegar in the treatment of atopic dermatitis

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

vinegar

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently reside in the USA
* Ability to comply with follow up visits at 2-4 months and at 6 months
* Come to the last follow-up at 6 months in the clinic
* At least 5% Body Surface Area (BSA) affected with AD

Exclusion Criteria

* Unclear diagnosis of atopic dermatitis
* Inability to comply with additive baths
* Inability to comply with follow-up visits
* Lack of residence in the United States
Minimum Eligible Age

6 Months

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HealthPartners Institute

OTHER

Sponsor Role collaborator

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Megha M. Tollefson, M.D.

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Megha M Tollefson, MD

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Sarah Asch, MD

Role: PRINCIPAL_INVESTIGATOR

HealthPartners Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic

Rochester, Minnesota, United States

Site Status

HealthPartners

Saint Paul, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014 Jul;71(1):116-32. doi: 10.1016/j.jaad.2014.03.023. Epub 2014 May 9.

Reference Type BACKGROUND
PMID: 24813302 (View on PubMed)

Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009 May;123(5):e808-14. doi: 10.1542/peds.2008-2217.

Reference Type BACKGROUND
PMID: 19403473 (View on PubMed)

Hon KL, Tsang YC, Lee VW, Pong NH, Ha G, Lee ST, Chow CM, Leung TF. Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial. J Dermatolog Treat. 2016;27(2):156-62. doi: 10.3109/09546634.2015.1067669. Epub 2015 Aug 13.

Reference Type BACKGROUND
PMID: 26270469 (View on PubMed)

Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, Blaser MJ. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016 Sep;75(3):481-493.e8. doi: 10.1016/j.jaad.2016.04.066.

Reference Type BACKGROUND
PMID: 27543211 (View on PubMed)

Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27.

Reference Type BACKGROUND
PMID: 24290431 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-006224

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Treatments on Atopic Dermatitis
NCT01631617 RECRUITING PHASE2
Moisturizer to Prevent Atopic Dermatitis
NCT03808532 WITHDRAWN PHASE2
Topical Steroid Formulation and Wet Wraps
NCT02680301 COMPLETED PHASE4